Topiramate
Epilepsy (monotherapy), Epilepsy (adjunctive therapy), Migraine prophylaxis
Indications
- Epilepsy (monotherapy)
- Epilepsy (adjunctive therapy)
- Migraine prophylaxis
Adult dosing
- epilepsy monotherapy: dose: 400; unit: mg/day; route: PO; interval: 400 mg/day in two divided doses; fixed: true; labelExcerpt: The recommended dose for topiramate monotherapy in adults and pediatric patients 10 years of age and older is 400 mg/day in two divided doses.
- epilepsy adjunctive: dose: 200; unit: mg/day; route: PO; interval: 200 mg/day to 400 mg/day in two divided doses; fixed: true; labelExcerpt: The recommended total daily dose of topiramate as adjunctive therapy in adults with partial-onset seizures or Lennox-Gastaut Syndrome is 200 mg/day to 400 mg/day in two divided doses
- migraine prophylaxis: dose: 100; unit: mg/day; route: PO; interval: 100 mg/day administered in two divided doses; fixed: true; labelExcerpt: The recommended total daily dose of topiramate as treatment for patients 12 years of age and older for the preventive treatment of migraine is 100 mg/day administered in two divided doses
Pediatric dosing
- epilepsy adjunctive: dose: 5; unit: mg/kg/day; route: PO; interval: 5 mg/kg/day to 9 mg/kg/day in two divided doses; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; labelExcerpt: The recommended total daily dose of topiramate as adjunctive therapy for pediatric patients 2 years to 16 years of age with partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome is approximately 5 mg/kg/day to 9 mg/kg/day
Renal adjustment
- moderate: one-half of the usual adult dose; severe: one-half of the usual adult dose; hemodialysis: Supplemental dose may be required; note: In patients with creatinine clearance less than 70 mL/min/1.73 m2, use half dose. Label: "In patients with renal impairment (creatinine clearance less than 70 mL/min/1.73 m 2 ), one-half of the usual adult dose of topiramate is recommended"
Hepatic adjustment
- Consult pharmacy/current label
Contraindications
- History of hypersensitivity to topiramate
Clinical pearls
- Monitor for acute myopia/secondary angle-closure glaucoma; discontinue if occurs.
- Monitor for decreased sweating and increased body temperature, especially in pediatric patients.
- Baseline and periodic serum bicarbonate monitoring is recommended to identify metabolic acidosis.
- Tablets should not be broken due to bitter taste; capsules may be sprinkled on soft food.
Source and review
- DailyMed label (topiramate), Set ID 2b6b0642-fb91-4641-9c51-d3be2021992b, effective 2026-10-07. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties